SHENASI ARANDA: Open Payments
NPI 1659929578 · DORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 16 payments from 8 companies in 2025. Trend: 2023 $237 · 2024 $427 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $91 |
| Exact Sciences Corporation | 3 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $15 |
Products named: XIFAXAN, The Cologuard Plus Collection Kit, Ozempic, Rybelsus, JARDIANCE, LEQVIO, ZENPEP, REXULTI.
Industry payments across FL — which companies pay providers there.
